[8-K] Coherus Oncology, Inc. Reports Material Event
Neuronetics, Inc. (STIM) 鈥� Form 144 filing discloses a planned insider sale.
- Seller: Stephen J. Furlong.
- Shares to be sold: 98,635 common shares, all derived from restricted-stock vesting between Jan 2022 and Feb 2025.
- Approximate sale date: 08/07/2025; broker: Fidelity Brokerage Services; exchange: NASDAQ.
- Estimated aggregate market value: $403,385.
- Issuer-reported shares outstanding: 66,124,820; proposed sale equals about 0.15 % of shares outstanding.
- Insider sold additional 200,000 shares during May 2025 for gross proceeds of $853,473.
The notice affirms that the seller possesses no undisclosed material adverse information and references Rule 10b5-1 compliance.
Neuronetics, Inc. (STIM) 鈥� Comunicazione Form 144 rivela una vendita pianificata da parte di un insider.
- Venditore: Stephen J. Furlong.
- Azioni da vendere: 98.635 azioni ordinarie, tutte derivanti dal vesting di azioni vincolate tra gennaio 2022 e febbraio 2025.
- Data approssimativa della vendita: 07/08/2025; intermediario: Fidelity Brokerage Services; borsa: NASDAQ.
- Valore di mercato aggregato stimato: 403.385 $.
- Azioni in circolazione riportate dall'emittente: 66.124.820; la vendita proposta corrisponde a circa lo 0,15% delle azioni in circolazione.
- L'insider ha venduto ulteriori 200.000 azioni a maggio 2025 per un ricavo lordo di 853.473 $.
La comunicazione conferma che il venditore non possiede informazioni materiali riservate e fa riferimento alla conformit脿 con la Regola 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Presentaci贸n del Formulario 144 revela una venta planificada por un insider.
- Vendedor: Stephen J. Furlong.
- Acciones a vender: 98,635 acciones ordinarias, todas derivadas del vesting de acciones restringidas entre enero de 2022 y febrero de 2025.
- Fecha aproximada de la venta: 07/08/2025; corredor: Fidelity Brokerage Services; bolsa: NASDAQ.
- Valor de mercado agregado estimado: 403,385 $.
- Acciones en circulaci贸n reportadas por el emisor: 66,124,820; la venta propuesta representa aproximadamente el 0.15% de las acciones en circulaci贸n.
- El insider vendi贸 adicionalmente 200,000 acciones en mayo de 2025 por ingresos brutos de 853,473 $.
El aviso afirma que el vendedor no posee informaci贸n material adversa no divulgada y hace referencia al cumplimiento de la Regla 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Form 144 鞝滌稖鞚� 雮措秬鞛愳潣 鞓堨爼霅� 欤检嫕 毵り皝鞚� 瓿店皽頃╇媹雼�.
- 韺愲Г鞛�: Stephen J. Furlong.
- 韺愲Г 鞓堨爼 欤检嫕 靾�: 98,635 氤错喌欤�, 氇憪 2022雲� 1鞗旊秬韯� 2025雲� 2鞗� 靷澊鞐� 鞝滍暅 欤检嫕鞚� 頇曥爼霅� 欤检嫕鞛呺媹雼�.
- 鞓堨儊 毵り皝鞚�: 2025雲� 8鞗� 7鞚�; 欷戧皽鞚�: Fidelity Brokerage Services; 瓯半灅靻�: NASDAQ.
- 於旍爼 齑� 鞁滌灔 臧�旃�: $403,385.
- 氚滍枆靷� 氤搓碃 欤检嫕 齑濎垬: 66,124,820欤�; 鞝滌晥霅� 毵り皝鞚� 齑� 欤检嫕鞚� 鞎� 0.15%鞐� 頃措嫻頃╇媹雼�.
- 雮措秬鞛愲姅 2025雲� 5鞗旍棎 於旉皜搿� 200,000欤�毳� 毵り皝頃橃棳 齑� 靾橃澋 $853,473毳� 旮半頄堨姷雼堧嫟.
鞚� 韱奠電� 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戩殧頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橃 鞎婌潓鞚� 頇曥澑頃橂┌, 攴滌箼 10b5-1 欷�靾橂ゼ 鞏戈笁頃╇媹雼�.
Neuronetics, Inc. (STIM) 鈥� D茅p么t du formulaire 144 r茅v猫le une vente pr茅vue par un initi茅.
- Vendeur : Stephen J. Furlong.
- Actions 脿 vendre : 98 635 actions ordinaires, toutes issues de l'acquisition d'actions restreintes entre janvier 2022 et f茅vrier 2025.
- Date approximative de la vente : 07/08/2025 ; courtier : Fidelity Brokerage Services ; bourse : NASDAQ.
- Valeur marchande totale estim茅e : 403 385 $.
- Actions en circulation d茅clar茅es par l'茅metteur : 66 124 820 ; la vente propos茅e repr茅sente environ 0,15 % des actions en circulation.
- L'initi茅 a vendu en outre 200 000 actions en mai 2025 pour un produit brut de 853 473 $.
L'avis confirme que le vendeur ne d茅tient aucune information mat茅rielle d茅favorable non divulgu茅e et fait r茅f茅rence 脿 la conformit茅 脿 la r猫gle 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Form 144 Meldung offenbart einen geplanten Insider-Verkauf.
- 痴别谤办盲耻蹿别谤: Stephen J. Furlong.
- Zu verkaufende Aktien: 98.635 Stammaktien, alle aus Restricted-Stock-Vesting zwischen Januar 2022 und Februar 2025.
- Ungef盲hres Verkaufsdatum: 07.08.2025; Broker: Fidelity Brokerage Services; B枚rse: NASDAQ.
- Gesch盲tzter Gesamtmarktwert: 403.385 $.
- Vom Emittenten gemeldete ausstehende Aktien: 66.124.820; der geplante Verkauf entspricht etwa 0,15 % der ausstehenden Aktien.
- Der Insider verkaufte im Mai 2025 zus盲tzlich 200.000 Aktien und erzielte einen Bruttoerl枚s von 853.473 $.
Die Mitteilung best盲tigt, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und verweist auf die Einhaltung der Regel 10b5-1.
- Sale equals only ~0.15 % of shares outstanding, indicating negligible dilution or control effect.
- Filing references Rule 10b5-1, suggesting pre-planned, compliant trading rather than opportunistic disposal.
- Insider intends to sell 98,635 shares on top of 200,000 sold in the previous three months.
- Clustered insider sales can be interpreted by investors as a bearish signal despite limited absolute size.
Insights
TL;DR Continued insider selling (鈮�298k shares in 3 mo.) signals modest negative sentiment but volume is only 0.45 % of float.
The filing adds another 98,635 shares to the 200,000 already sold since May 2025. While dollar amounts are small (<$1.3 m combined) and represent less than one-half percent of outstanding shares, serial sales can be interpreted as weak insider conviction. No earnings or operational data are provided, limiting fundamental read-through, yet investors often treat clustered sales as a caution flag. The Rule 10b5-1 statement reduces the likelihood of information asymmetry but does not eliminate perception risk. Overall impact: slightly negative.
TL;DR Filing appears procedurally sound; sale size immaterial to control鈥攏eutral governance impact.
Form 144 includes required acquisition history, sale timing and broker details, suggesting compliance with SEC rules. The seller represents awareness of no undisclosed adverse information, aligning with best-practice disclosures. Percentage of ownership change is minimal, so no governance or control implications arise. Therefore, from a governance standpoint the event is routine and not materially impactful.
Neuronetics, Inc. (STIM) 鈥� Comunicazione Form 144 rivela una vendita pianificata da parte di un insider.
- Venditore: Stephen J. Furlong.
- Azioni da vendere: 98.635 azioni ordinarie, tutte derivanti dal vesting di azioni vincolate tra gennaio 2022 e febbraio 2025.
- Data approssimativa della vendita: 07/08/2025; intermediario: Fidelity Brokerage Services; borsa: NASDAQ.
- Valore di mercato aggregato stimato: 403.385 $.
- Azioni in circolazione riportate dall'emittente: 66.124.820; la vendita proposta corrisponde a circa lo 0,15% delle azioni in circolazione.
- L'insider ha venduto ulteriori 200.000 azioni a maggio 2025 per un ricavo lordo di 853.473 $.
La comunicazione conferma che il venditore non possiede informazioni materiali riservate e fa riferimento alla conformit脿 con la Regola 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Presentaci贸n del Formulario 144 revela una venta planificada por un insider.
- Vendedor: Stephen J. Furlong.
- Acciones a vender: 98,635 acciones ordinarias, todas derivadas del vesting de acciones restringidas entre enero de 2022 y febrero de 2025.
- Fecha aproximada de la venta: 07/08/2025; corredor: Fidelity Brokerage Services; bolsa: NASDAQ.
- Valor de mercado agregado estimado: 403,385 $.
- Acciones en circulaci贸n reportadas por el emisor: 66,124,820; la venta propuesta representa aproximadamente el 0.15% de las acciones en circulaci贸n.
- El insider vendi贸 adicionalmente 200,000 acciones en mayo de 2025 por ingresos brutos de 853,473 $.
El aviso afirma que el vendedor no posee informaci贸n material adversa no divulgada y hace referencia al cumplimiento de la Regla 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Form 144 鞝滌稖鞚� 雮措秬鞛愳潣 鞓堨爼霅� 欤检嫕 毵り皝鞚� 瓿店皽頃╇媹雼�.
- 韺愲Г鞛�: Stephen J. Furlong.
- 韺愲Г 鞓堨爼 欤检嫕 靾�: 98,635 氤错喌欤�, 氇憪 2022雲� 1鞗旊秬韯� 2025雲� 2鞗� 靷澊鞐� 鞝滍暅 欤检嫕鞚� 頇曥爼霅� 欤检嫕鞛呺媹雼�.
- 鞓堨儊 毵り皝鞚�: 2025雲� 8鞗� 7鞚�; 欷戧皽鞚�: Fidelity Brokerage Services; 瓯半灅靻�: NASDAQ.
- 於旍爼 齑� 鞁滌灔 臧�旃�: $403,385.
- 氚滍枆靷� 氤搓碃 欤检嫕 齑濎垬: 66,124,820欤�; 鞝滌晥霅� 毵り皝鞚� 齑� 欤检嫕鞚� 鞎� 0.15%鞐� 頃措嫻頃╇媹雼�.
- 雮措秬鞛愲姅 2025雲� 5鞗旍棎 於旉皜搿� 200,000欤�毳� 毵り皝頃橃棳 齑� 靾橃澋 $853,473毳� 旮半頄堨姷雼堧嫟.
鞚� 韱奠電� 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戩殧頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橃 鞎婌潓鞚� 頇曥澑頃橂┌, 攴滌箼 10b5-1 欷�靾橂ゼ 鞏戈笁頃╇媹雼�.
Neuronetics, Inc. (STIM) 鈥� D茅p么t du formulaire 144 r茅v猫le une vente pr茅vue par un initi茅.
- Vendeur : Stephen J. Furlong.
- Actions 脿 vendre : 98 635 actions ordinaires, toutes issues de l'acquisition d'actions restreintes entre janvier 2022 et f茅vrier 2025.
- Date approximative de la vente : 07/08/2025 ; courtier : Fidelity Brokerage Services ; bourse : NASDAQ.
- Valeur marchande totale estim茅e : 403 385 $.
- Actions en circulation d茅clar茅es par l'茅metteur : 66 124 820 ; la vente propos茅e repr茅sente environ 0,15 % des actions en circulation.
- L'initi茅 a vendu en outre 200 000 actions en mai 2025 pour un produit brut de 853 473 $.
L'avis confirme que le vendeur ne d茅tient aucune information mat茅rielle d茅favorable non divulgu茅e et fait r茅f茅rence 脿 la conformit茅 脿 la r猫gle 10b5-1.
Neuronetics, Inc. (STIM) 鈥� Form 144 Meldung offenbart einen geplanten Insider-Verkauf.
- 痴别谤办盲耻蹿别谤: Stephen J. Furlong.
- Zu verkaufende Aktien: 98.635 Stammaktien, alle aus Restricted-Stock-Vesting zwischen Januar 2022 und Februar 2025.
- Ungef盲hres Verkaufsdatum: 07.08.2025; Broker: Fidelity Brokerage Services; B枚rse: NASDAQ.
- Gesch盲tzter Gesamtmarktwert: 403.385 $.
- Vom Emittenten gemeldete ausstehende Aktien: 66.124.820; der geplante Verkauf entspricht etwa 0,15 % der ausstehenden Aktien.
- Der Insider verkaufte im Mai 2025 zus盲tzlich 200.000 Aktien und erzielte einen Bruttoerl枚s von 853.473 $.
Die Mitteilung best盲tigt, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen besitzt und verweist auf die Einhaltung der Regel 10b5-1.
FAQ
How many Neuronetics (STIM) shares are being sold under this Form 144?
What is the estimated value of the planned STIM insider sale?
When is the anticipated sale date for the 98,635 STIM shares?
How many shares has the same insider sold recently?
What percentage of Neuronetics' outstanding shares does the planned sale represent?
